Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months
<p>Abstract</p> <p>Background</p> <p>Development and deployment of an effective malaria vaccine would complement existing malaria control measures. A blood stage malaria vaccine candidate, Merozoite Surface Protein-3 (MSP3), produced as a long synthetic peptide, has bee...
Main Authors: | Segeja Method D, Minja Daniel, Rutta Acleus, Sembuche Samwel, Seth Misago, Lemnge Martha, Francis Filbert, Msham Salum, Gesase Samwel, Lusingu John PA, Bosomprah Samuel, Cousens Simon, Noor Ramadhani, Chilengi Roma, Druilhe Pierre |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/8/1/163 |
Similar Items
-
Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania
by: Francis Filbert, et al.
Published: (2009-07-01) -
Using community-owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north-eastern Tanzania
by: Rutta Acleus S M, et al.
Published: (2012-05-01) -
Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania
by: Lusingu John P, et al.
Published: (2010-03-01) -
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
by: Matthew Cairns, et al.
Published: (2010-03-01) -
E-learning uptake among academicians and students in Tanzanian universities
by: Simeo Boniphace Kisanjara, et al.
Published: (2019-01-01)